glp 1 agonist novo nordisk expands patient access to authentic, FDA-approved Wegovy® via collaborations with multiple telehealth organizations Novo, Lilly Stocks Rise. Weight-Loss

Constipation is a shared struggle for both IBS-C sufferers and individuals on GLP-1 medications

Methods In accordance with the PRISMA guidelines, we systematically searched PubMed, Embase, Cochrane Library, Web of Science, Scopus, and LILACS for randomized controlled trials and observational studies published between 2000 and 2025

GLP-1 medications may curb appetite, but they're also reshaping budgets and boosting intentional living.

You do not need to involve insurance

Type 2 diabetes mellitus (T2DM) is a widespread metabolic disorder characterized by insulin resistance and pancreatic -cell dysfunction, posing a substantial global health challenge

Considerations regarding adverse effects and contraindications for different drug classes are provided to help guide treatment decision-making when considering pharmacotherapy for weight management in patients with obesity.